145 related articles for article (PubMed ID: 7685088)
1. Racial differences in maternal serum human chorionic gonadotropin and unconjugated oestriol levels.
Kulch P; Keener S; Matsumoto M; Crandall BF
Prenat Diagn; 1993 Mar; 13(3):191-5. PubMed ID: 7685088
[TBL] [Abstract][Full Text] [Related]
2. Adjustment formulae for maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol to maternal weight and smoking.
Bartels I; Hoppe-Sievert B; Bockel B; Herold S; Caesar J
Prenat Diagn; 1993 Feb; 13(2):123-30. PubMed ID: 7681977
[TBL] [Abstract][Full Text] [Related]
3. Effect of allowing for ethnic group in prenatal screening for Down's syndrome.
Watt HC; Wald NJ; Smith D; Kennard A; Densem J
Prenat Diagn; 1996 Aug; 16(8):691-8. PubMed ID: 8878277
[TBL] [Abstract][Full Text] [Related]
4. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
5. Human chorionic gonadotropin and unconjugated oestriol measurements in insulin-dependent diabetic pregnant women being screened for fetal Down syndrome.
Palomaki GE; Knight GJ; Haddow JE
Prenat Diagn; 1994 Jan; 14(1):65-8. PubMed ID: 7514290
[TBL] [Abstract][Full Text] [Related]
6. Second-trimester diurnal variation of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol: is it present and does it affect the prediction of a patient's risk for fetal Down syndrome?
Rose NC; Canick JA; Knight GJ; Pulkkinen A; Tumber MB; Mennuti MT; Palomaki GE
Prenat Diagn; 1994 Oct; 14(10):947-51. PubMed ID: 7534924
[TBL] [Abstract][Full Text] [Related]
7. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
Extermann P; Bischof P; Marguerat P; Mermillod B
Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261
[TBL] [Abstract][Full Text] [Related]
8. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome.
Wald NJ; Cuckle HS; Densem JW; Stone RB
Br J Obstet Gynaecol; 1992 Jan; 99(1):51-3. PubMed ID: 1372176
[TBL] [Abstract][Full Text] [Related]
9. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
Liao S; Wang Y; Ye G
Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
[TBL] [Abstract][Full Text] [Related]
10. First-trimester maternal serum unconjugated oestriol and alpha-fetoprotein in fetal Down's syndrome.
Crandall BF; Golbus MS; Goldberg JD; Matsumoto M
Prenat Diagn; 1991 Jun; 11(6):377-80. PubMed ID: 1717969
[TBL] [Abstract][Full Text] [Related]
11. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction.
Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB
Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282
[TBL] [Abstract][Full Text] [Related]
12. First-trimester maternal serum biochemical indicators in Down syndrome.
Brock DJ; Barron L; Holloway S; Liston WA; Hillier SG; Seppala M
Prenat Diagn; 1990 Apr; 10(4):245-51. PubMed ID: 1694994
[TBL] [Abstract][Full Text] [Related]
13. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
[TBL] [Abstract][Full Text] [Related]
14. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome.
Wald N; Cuckle H; Wu TS; George L
Br J Obstet Gynaecol; 1991 Sep; 98(9):905-8. PubMed ID: 1716981
[TBL] [Abstract][Full Text] [Related]
15. Maternal smoking: age distribution, levels of alpha-fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second-trimester screening.
Crossley JA; Aitken DA; Waugh SM; Kelly T; Connor JM
Prenat Diagn; 2002 Mar; 22(3):247-55. PubMed ID: 11920904
[TBL] [Abstract][Full Text] [Related]
16. Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin.
Palomaki GE; Haddow JE; Knight GJ; Wald NJ; Kennard A; Canick JA; Saller DN; Blitzer MG; Dickerman LH; Fisher R
Prenat Diagn; 1995 Aug; 15(8):713-23. PubMed ID: 7479589
[TBL] [Abstract][Full Text] [Related]
17. Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening.
Berry E; Aitken DA; Crossley JA; Macri JN; Connor JM
Prenat Diagn; 1995 Jun; 15(6):555-65. PubMed ID: 7544898
[TBL] [Abstract][Full Text] [Related]
18. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.
Kellner LH; Weiner Z; Weiss RR; Neuer M; Martin GM; Mueenuddin M; Bombard A
Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343
[TBL] [Abstract][Full Text] [Related]
19. Screening for Down syndrome at 14 weeks of pregnancy.
Wald NJ; Watt HC; Haddow JE; Knight GJ
Prenat Diagn; 1998 Mar; 18(3):291-3. PubMed ID: 9556047
[TBL] [Abstract][Full Text] [Related]
20. Risk of abnormal triple screen for Down syndrome is significantly higher in patients with female fetuses.
Spong CY; Ghidini A; Stanley-Christian H; Meck JM; Seydel FD; Pezzullo JC
Prenat Diagn; 1999 Apr; 19(4):337-9. PubMed ID: 10327139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
